Caristo Diagnostics Secures $150,000 in Funding to Revolutionize Cardiovascular Diagnosis

Caristo Diagnostics is thrilled to announce a successful funding round, raising $150,000 to fuel the advancement of our groundbreaking cardiovascular diagnostic tools. Founded with the mission to revolutionize the landscape of cardiac healthcare, Caristo Diagnostics is dedicated to improving patient outcomes by enhancing the accuracy of routine cardiac CT scans. Our proprietary technology meticulously extracts vital information hidden within these scans, which empowers healthcare professionals to better predict cardiovascular risks and make informed treatment decisions. This influx of capital will allow us to further develop our innovative technology, expand our research initiatives, and increase our market presence to ensure that our cutting-edge solutions reach patients across the globe. With cardiovascular diseases continuing to be a leading cause of morbidity and mortality, our commitment to refining diagnostic accuracy is more critical than ever. By harnessing advanced imaging techniques, Caristo seeks to not only improve the lives of patients but also to transform the standard of care in cardiovascular diagnostics. We invite you to follow our journey and stay updated on our progress by visiting our website at [Caristo.com](https://www.caristo.com) and following us on Twitter at [@CaristoHeart](https://twitter.com/CaristoHeart). This funding is just the beginning as we work towards a healthier future and strive to deliver exceptional cardiac care worldwide. Thank you to all our supporters for believing in our vision and helping us translate innovative technology into invaluable healthcare solutions.